cefazolin has been researched along with Infections, Soft Tissue in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, DE; Kanaya, F; Mayer, KH; Szumowski, JD | 1 |
| Blyth, DM; Carson, ML; Lloyd, BA; Murray, CK; Schnaubelt, ER; Shaikh, F; Tribble, DR; Whitman, TJ | 1 |
| Campbell, SG; Dalen, D; Eppler, J; Fry, A; Zed, PJ | 1 |
| Bamal, R; Bindra, R; Matthews, J; McLean, A | 1 |
| Hatef, DA; Janis, JE; Reece, EM; Wong, C | 1 |
| Housman, ST; Jain, JG; Nicolau, DP | 1 |
| Gu, JH; Jeon, HB | 1 |
| Berry, J; Cavanaugh, DL; Dahners, LE; Yarboro, SR | 1 |
| Cox, VC; Zed, PJ | 1 |
| Bolash, NK; Liu, HH; Lynch, RA; McAnany, ME | 1 |
1 review(s) available for cefazolin and Infections, Soft Tissue
| Article | Year |
|---|---|
Once-daily cefazolin and probenecid for skin and soft tissue infections.
Topics: Anti-Bacterial Agents; Biological Availability; Cefazolin; Half-Life; Humans; Male; Probenecid; Randomized Controlled Trials as Topic; Skin Diseases, Infectious; Soft Tissue Infections; Treatment Outcome; Uricosuric Agents | 2004 |
2 trial(s) available for cefazolin and Infections, Soft Tissue
| Article | Year |
|---|---|
Does empiric antibiotic therapy change MRSA [corrected] hand infection outcomes? Cost analysis of a randomized prospective trial in a county hospital.
Topics: Abscess; Adult; Anti-Bacterial Agents; Cefazolin; Community-Acquired Infections; Cost-Benefit Analysis; Costs and Cost Analysis; Female; Hand; Hospital Costs; Hospitals, County; Humans; Length of Stay; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Soft Tissue Infections; Staphylococcal Infections; Vancomycin | 2014 |
Susceptibility of bacterial isolates from complicated skin and skin structure infections to cefazolin, imipenem-cilastatin, ciprofloxacin and ofloxacin.
Topics: Adolescent; Adult; Anti-Infective Agents; Bacteria; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Ofloxacin; Skin Diseases, Bacterial; Soft Tissue Infections | 1995 |
7 other study(ies) available for cefazolin and Infections, Soft Tissue
| Article | Year |
|---|---|
Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.
Topics: Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Boston; Female; HIV Infections; Humans; Male; Methicillin Resistance; Middle Aged; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome | 2007 |
Early infectious outcomes after addition of fluoroquinolone or aminoglycoside to posttrauma antibiotic prophylaxis in combat-related open fracture injuries.
Topics: Adult; Afghan Campaign 2001-; Aminoglycosides; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Clindamycin; Drug Therapy, Combination; Female; Fluoroquinolones; Fractures, Open; Humans; Injury Severity Score; Iraq War, 2003-2011; Length of Stay; Male; Military Personnel; Osteomyelitis; Proportional Hazards Models; Skin Diseases, Infectious; Soft Tissue Infections; United States | 2017 |
Intravenous cefazolin plus oral probenecid versus oral cephalexin for the treatment of skin and soft tissue infections: a double-blind, non-inferiority, randomised controlled trial.
Topics: Adjuvants, Pharmaceutic; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Canada; Cefazolin; Cephalexin; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Probenecid; Prospective Studies; Soft Tissue Infections | 2018 |
Bacteriological profile of community-acquired musculoskeletal infections: a study from Queensland.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Arthritis, Infectious; Australia; Cefazolin; Child; Child, Preschool; Community-Acquired Infections; Female; Floxacillin; Hospitalization; Humans; Infant; Infant, Newborn; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Musculoskeletal Diseases; Osteomyelitis; Queensland; Retrospective Studies; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Young Adult | 2018 |
Humanized tissue pharmacodynamics of cefazolin against commonly isolated pathogens in skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cefazolin; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Models, Theoretical; Skin Diseases; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus | 2014 |
Pyogenic flexor tenosynovitis after intralesional injection of triamcinolone acetonide by jet injector (Dermojet®).
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cefazolin; Humans; Injections, Intralesional; Male; Psoriasis; Soft Tissue Infections; Staphylococcal Infections; Tenosynovitis; Triamcinolone Acetonide | 2015 |
Better prophylaxis against surgical site infection with local as well as systemic antibiotics. An in vivo study.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Cefazolin; Disease Models, Animal; Gentamicins; Injections; Male; Rats; Rats, Sprague-Dawley; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus | 2009 |